ARK Genomic Revolution ETF (BATS:ARKG) Hits New 1-Year High – Here’s What Happened

ARK Genomic Revolution ETF (BATS:ARKG)’s share price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $51.32 and last traded at $51.9010, with a volume of 2825670 shares changing hands. The stock had previously closed at $47.85.

ARK Genomic Revolution ETF Stock Performance

The stock has a 50-day simple moving average of $43.68 and a 200-day simple moving average of $35.75.

Institutional Trading of ARK Genomic Revolution ETF

Several large investors have recently added to or reduced their stakes in the stock. Ascentis Independent Advisors purchased a new stake in shares of ARK Genomic Revolution ETF during the first quarter valued at approximately $26,000. PNC Financial Services Group Inc. grew its holdings in ARK Genomic Revolution ETF by 53.2% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,088 shares of the company’s stock worth $29,000 after acquiring an additional 378 shares in the last quarter. Western Wealth Management LLC bought a new stake in shares of ARK Genomic Revolution ETF in the 1st quarter worth about $37,000. AlphaCore Capital LLC bought a new stake in shares of ARK Genomic Revolution ETF in the 4th quarter worth about $39,000. Finally, Hilton Head Capital Partners LLC raised its stake in shares of ARK Genomic Revolution ETF by 161.4% in the 1st quarter. Hilton Head Capital Partners LLC now owns 1,537 shares of the company’s stock valued at $41,000 after purchasing an additional 949 shares in the last quarter.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.